Associated Papers
Molecular insights into CYP19A1 mutations and their role in estrogen production.
Lee YB et al.
Archives of Biochemistry and Biophysics, 2025
Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients.
Yin X et al.
Nature Communications, 2025
40044664 (PubMed )
Supplement: 41467_2025_57520_MOESM8_ESM.xlsx › Supplementary_Data_4_pathogenic
In silico analysis of nsSNPs in CYP19A1 gene affecting breast cancer associated aromatase enzyme.
Pavithran H et al.
Journal of Genetics, 2021
Adenomyosis: genetics of estrogen metabolism.
Artymuk N et al.
Hormone Molecular Biology and Clinical Investigation, 2019
Role of cytochrome P450 genes in breast cancer etiology and treatment: effects on estrogen biosynthesis, metabolism, and response to endocrine therapy.
Blackburn HL et al.
Cancer Causes & Control : Ccc, 2015
A non-synonymous coding change in the CYP19A1 gene Arg264Cys (rs700519) does not affect circulating estradiol, bone structure or fracture.
Wang JZ et al.
Bmc Medical Genetics, 2011
Identification of CYP19A1 single-nucleotide polymorphisms and their haplotype distributions in a Korean population.
Lee SJ et al.
Journal of Human Genetics, 2010
Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment.
Rodriguez-Antona C et al.
Human Genetics, 2010
Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients.
Fasching PA et al.
Breast Cancer Research and Treatment, 2008
A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches.
Olson JE et al.
Breast Cancer Research and Treatment, 2007
Human aromatase: gene resequencing and functional genomics.
Ma CX et al.
Cancer Research, 2005
Select a paper to view details